Literature DB >> 11408449

Periarticular cancellous bone changes following anterior cruciate ligament injury.

G R Wohl1, R C Shymkiw, J R Matyas, R Kloiber, R F Zernicke.   

Abstract

To understand more fully the early bone changes in an experimental model of osteoarthrosis, we quantified periarticular bone mineral density and bone mechanical properties in anterior cruciate ligament transected (ACLX) knee joints (4, 10, 32, and 39 wk post-ACLX) compared with contralateral joints and unoperated normal joints of skeletally mature animals. Maximal stress and energy were significantly reduced in ACLX cancellous bone from the medial femoral condyles at 4 wk postinjury. All mechanical properties (e.g., yield stress and elastic modulus) declined after 4 wk and were significantly reduced at 10 wk. ACLX bone mineral density was significantly reduced at all measured time points. Ash content was significantly reduced at 10 and 32 wk. Changes in the lateral condyles were similar but less pronounced than in the medial condyles. These bony changes accompanied the earliest articular cartilage molecular changes and preceded changes in the articular cartilage gross morphology. We suggest that these early changes in bone mechanical behavior contribute to the progression of osteoarthrosis and pathogenic changes in the joint.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11408449     DOI: 10.1152/jappl.2001.91.1.336

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

Review 1.  Role of bone architecture and anatomy in osteoarthritis.

Authors:  Julie C Baker-LePain; Nancy E Lane
Journal:  Bone       Date:  2012-01-24       Impact factor: 4.398

2.  Cartilage and bone changes during development of post-traumatic osteoarthritis in selected LGXSM recombinant inbred mice.

Authors:  S Hashimoto; M F Rai; K L Janiszak; J M Cheverud; L J Sandell
Journal:  Osteoarthritis Cartilage       Date:  2012-02-08       Impact factor: 6.576

3.  Alpha C-telopeptide of type I collagen is associated with subchondral bone turnover and predicts progression of joint space narrowing and osteophytes in osteoarthritis.

Authors:  Janet L Huebner; Anne C Bay-Jensen; Kim M Huffman; Yi He; Diana J Leeming; Gary E McDaniel; Morten A Karsdal; Virginia B Kraus
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

4.  Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.

Authors:  M A Karsdal; I Byrjalsen; A C Bay-Jensen; K Henriksen; B J Riis; C Christiansen
Journal:  BMC Musculoskelet Disord       Date:  2010-06-17       Impact factor: 2.362

Review 5.  Functional attachment of soft tissues to bone: development, healing, and tissue engineering.

Authors:  Helen H Lu; Stavros Thomopoulos
Journal:  Annu Rev Biomed Eng       Date:  2013-04-29       Impact factor: 9.590

6.  Characterization of an Ex vivo Femoral Head Model Assessed by Markers of Bone and Cartilage Turnover.

Authors:  Suzi Hoegh Madsen; Anne Sofie Goettrup; Gedske Thomsen; Søren Tvorup Christensen; Nikolaj Schultz; Kim Henriksen; Anne-Christine Bay-Jensen; Morten Asser Karsdal
Journal:  Cartilage       Date:  2011-07       Impact factor: 4.634

7.  Primary Osteoarthritis Early Joint Degeneration Induced by Endoplasmic Reticulum Stress Is Mitigated by Resveratrol.

Authors:  Jacqueline T Hecht; Alka C Veerisetty; Juliana Wu; Francoise Coustry; Mohammad G Hossain; Frankie Chiu; Francis H Gannon; Karen L Posey
Journal:  Am J Pathol       Date:  2021-06-08       Impact factor: 5.770

8.  Calcitonin attenuates cartilage degeneration and nociception in an experimental rat model of osteoarthritis: role of TGF-β in chondrocytes.

Authors:  Zhi-Hong Wen; Chi-Chieh Tang; Yi-Chen Chang; Shi-Ying Huang; Yen-You Lin; Shih-Peng Hsieh; Hsin-Pai Lee; Sung-Chun Lin; Wu-Fu Chen; Yen-Hsuan Jean
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.